Article info
PDFResponse
True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw
- Correspondence to Dr Roland Kipke, International Centre for Ethics in the Sciences and Humanities, Tübingen University, Wilhelmstrasse 19, 72074 Tübingen, Germany;kipke{at}izew.uni-tuebingen.de
Citation
True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw
Publication history
- Received January 2, 2013
- Revised February 1, 2013
- Accepted February 6, 2013
- First published March 6, 2013.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Cognitive neuroenhancement: false assumptions in the ethical debate
- Neuroenhancers, addiction and research ethics
- Sugar addiction: is it real? A narrative review
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
- Neuropsychiatry of the basal ganglia
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Neuroenhancing public health
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- The billion dollar business of being smart
- GL.01 Dopamine in health and disease